Tacrolimus Suppliers & Bulk Manufacturers

Available Forms: Capsule

Available Strengths: IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg

Reference Brands: US: Prograf IR, Astagraf XL; EU: Prograf,Advagraf(PR)

Category: Oncology Cancer Care

Tacrolimus Capsules are immunosuppressive agents used to prevent organ transplant rejection. Available in 0.5 mg, 1 mg, 3 mg, 4 mg, and 5 mg strengths in both immediate-release and extended-release forms across the U.S. and EU, they support personalized post-transplant care. Ideal for B2B pharma supply. Tacrolimus is available in Capsule and strengths such as IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tacrolimus is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Tacrolimus can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Tacrolimus Capsules are essential immunosuppressants widely used in organ transplant patients to prevent rejection. Available in both immediate-release (Prograf) and extended-release forms (Astagraf XL, Envarsus), these capsules are offered in strengths of 0.5 mg, 1 mg, 3 mg, 4 mg, and 5 mg across the U.S. and EU markets. Tacrolimus effectively inhibits T-lymphocyte activation, making it a vital part of post-transplant care. With multiple dosing options, it supports individualized therapy. Suitable for B2B pharmaceutical distribution, Tacrolimus capsules are available in branded and generic forms, ensuring broad accessibility and cost-effective solutions for hospitals, clinics, and healthcare providers in Europe and the U.S.